Spire Wealth Management Nuvalent, Inc. Transaction History
Spire Wealth Management
- $3.02 Billion
- Q1 2025
A detailed history of Spire Wealth Management transactions in Nuvalent, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 140 shares of NUVL stock, worth $10,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140Holding current value
$10,932% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.4 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$411 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$236 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$145 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.36B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...